Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
24.7M
-
Shares change
-
-759K
-
Total reported value, excl. options
-
$58M
-
Value change
-
-$3.59M
-
Number of buys
-
22
-
Number of sells
-
-28
-
Price
-
$2.39
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2018
63 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2018.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.7M shares
of 237M outstanding shares and own 10.43% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.52M shares), Consonance Capital Management LP (4.59M shares), Broadfin Capital, LLC (4.23M shares), Aisling Capital LLC (3.61M shares), Vanguard Group Inc (1.33M shares), BlackRock Inc. (964K shares), 683 Capital Management, LLC (805K shares), MORGENS WATERFALL VINTIADIS & CO INC (400K shares), UBS Group AG (351K shares), and STATE STREET CORP (311K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.